Online citations, reference lists, and bibliographies.
← Back to Search

Lipidic Implants For Controlled Release Of Bioactive Insulin: Effects On Cartilage Engineered In Vitro.

B. Appel, A. Maschke, B. Weiser, H. Sarhan, C. Englert, P. Angele, T. Blunk, A. Göpferich
Published 2006 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Controlled release systems for growth factors and morphogens are potentially powerful tools for the engineering or the treatment of living tissues. However, due to possible instabilities of the protein during manufacture, storage, and release, in the development of new release systems it is paramount to investigate into the maintenance of bioactivity of the protein. Within this study, recently developed protein releasing lipid matrix cylinders of 2 mm diameter and 2 mm height made from glycerol tripalmitate were manufactured in a compression process without further additives. Insulin in different concentrations (0.2%, 1%, and 2%) served as model protein. The bioactivity of the protein released from the matrices was investigated in a long-term cartilage engineering culture for up to four weeks; additionally, the release profiles were determined using ELISA. Insulin released from the matrices increased the wet weights of the cartilaginous cell-polymer constructs (up to 3.2-fold), the amount of GAG and collagen in the constructs (up to 2.4-fold and 3.2-fold, respectively) and the GAG and collagen content per cell (1.8-fold and 2.5-fold, respectively), compared to the control. The dose-dependent effects on tissue development correlated well with release profiles from the matrices with different insulin loading. In conclusion, the lipid matrices, preserving the bioactivity of incorporated and released protein, are suggested as a suitable carrier system for use in tissue engineering or for the localized treatment of tissues with highly potent protein drugs such as used in the therapy of brain cancer or neurodegenerative CNS diseases.
This paper references
10.1002/JPS.20009
Microparticulate formulations for the controlled release of interleukin-2.
Tommy T. Thomas (2004)
10.1201/9781003067542-1
STABILITY OF PROTEINS AND THEIR DELIVERY FROM BIODEGRADABLE POLYMER MICROSPHERES
S. Schwendeman (1996)
10.1016/0003-9861(61)90291-0
The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.
J. F. Wößner (1961)
10.1016/S0168-3659(03)00263-3
Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs.
K. Surendrakumar (2003)
10.1172/JCI117156
Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay.
A. Hollander (1994)
10.1053/JOCA.2002.0813
A slow release formulation of insulin as a treatment for osteoarthritis.
L. Cai (2002)
10.1023/A:1011074915438
Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer
Y. Kim (2004)
10.1023/A:1007502828372
Growth Factor Delivery for Tissue Engineering
J. Babensee (2004)
10.1021/bk-2004-0879.ch013
Lipids: An alternative material for protein and peptide release
A. Maschke (2004)
10.1023/A:1007513425337
Stabilization of Proteins Encapsulated in Cylindrical Poly(lactide-co-glycolide) Implants: Mechanism of Stabilization by Basic Additives
Gaozhong Zhu (2004)
Tissue engineering : Frontiers in biotechnology
R. Langer (1993)
10.1007/BF01081408
A new basic metachromatic dye, 1∶9-Dimethyl Methylene Blue
K. B. Taylor (2005)
10.1089/10763270360696941
Tissue regeneration based on growth factor release.
Y. Tabata (2003)
10.1016/0304-4165(86)90306-5
Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.
R. Farndale (1986)
10.1016/0003-2697(88)90532-5
Fluorometric assay of DNA in cartilage explants using Hoechst 33258.
Y. Kim (1988)
10.1002/JBM.820270104
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers.
L. Freed (1993)
10.1016/S0939-6411(02)00138-8
Acylation of peptides by lactic acid solutions.
A. Lucke (2003)
Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.
J. Brange (1992)
10.1023/B:PHAM.0000008050.99985.5c
Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer Depot in ZDF Rats
Suna Choi (2004)
10.1038/71916
Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide)
Gaozhong Zhu (2000)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/J.JCONREL.2003.12.013
Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics.
L. Dellamary (2004)
10.1038/71875
Protein stability in controlled-release systems
K. Fu (2000)
10.1016/S0168-3659(02)00020-2
The effect of poly(ethylene glycol)-poly(D,L-lactic acid) diblock copolymers on peptide acylation.
A. Lucke (2002)
10.1007/978-1-4899-1236-7_11
Insulin structure and stability.
J. Brange (1993)
10.1016/S0939-6411(02)00137-6
Monolithic glyceryl trimyristate matrices for parenteral drug release applications.
W. Vogelhuber (2003)
10.3109/10611860108998778
Insulin in Tissue Engineering of Cartilage: A Potential Model System for Growth Factor Application
K. Kellner (2001)
10.1114/1.205
Method for Quantitative Analysis of Glycosaminoglycan Distribution in Cultured Natural and Engineered Cartilage
I. Martin (2004)



This paper is referenced by
Industrial ram extrusion as innovative tool for the development of biodegradable sustained release implants
Martina Sprengholz (2014)
Extruded lipid implants for intravitreal use - protein stability, release kinetics and process design
Moritz Vollrath (2017)
10.1016/J.BPRINT.2018.E00027
Composites of fatty acids and ceramic powders are versatile biomaterials for personalized implants and controlled release of pharmaceuticals
M. B. Jensen (2018)
10.1016/j.actbio.2010.12.014
Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: investigation for cartilage tissue engineering.
K. Andreas (2011)
10.1016/j.injury.2008.01.036
Smart biomaterials for tissue engineering of cartilage.
Reinout Stoop (2008)
10.1016/j.joca.2009.05.002
Synergistic effects of growth and differentiation factor-5 (GDF-5) and insulin on expanded chondrocytes in a 3-D environment.
B. Appel (2009)
Cartilage tissue engineering for auricular reconstruction.Cartilage constructs in complex shape & differentiation processes
J. Baumer (2011)
10.1007/s00264-012-1726-z
Insulin is essential for in vitro chondrogenesis of mesenchymal progenitor cells and influences chondrogenesis in a dose-dependent manner
Michael B. Mueller (2012)
10.1016/J.JCONREL.2007.02.008
Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices.
S. Koennings (2007)
10.1016/J.ADDR.2007.03.020
Matrices and scaffolds for protein delivery in tissue engineering.
Joerg K V Tessmar (2007)
10.1007/s11095-007-9258-8
Confocal Microscopy for the Elucidation of Mass Transport Mechanisms Involved in Protein Release from Lipid-based Matrices
S. Koennings (2007)
10.1089/ten.TEA.2008.0679
The effect of insulin-loaded chitosan particle-aggregated scaffolds in chondrogenic differentiation.
P. B. Malafaya (2010)
10.1007/s11095-016-1979-0
Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?
Sharan Bobbala (2016)
10.1016/j.ejpb.2018.06.016
New insights into process understanding of solid lipid extrusion (SLE) of extruded lipid implants for sustained protein delivery
Moritz Vollrath (2018)
10.1021/mp3001099
Lipase is essential for the study of in vitro release kinetics from organogels.
Marie-Hélène Dufresne (2012)
10.1016/j.ejpb.2017.04.017
Long‐term release and stability of pharmaceutical proteins delivered from solid lipid implants
Moritz Vollrath (2017)
10.1016/j.jconrel.2010.07.110
The mechanism of protein release from triglyceride microspheres.
A. Zaky (2010)
10.1002/term.1517
Foamed oligo(poly(ethylene glycol)fumarate) hydrogels as versatile prefabricated scaffolds for tissue engineering
M. Henke (2014)
10.17795/JJNPP-16414
Development, Characterizations and Biocompatibility Evaluations of Intravitreal Lipid Implants
L. Tamaddon (2014)
Development of lipid based depot formulations using interferon-beta-1b as a model protein
Christian Neuhofer (2015)
10.1007/978-1-4939-1417-3_12
Implants as Sustained Release Delivery Devices for Vaccine Antigens
Julia Engert (2015)
Cartilage tissue engineering: controlled release of growth factors. Effects of GDF-5, sexual steroid hormons and oxygen
B. Appel (2007)
10.1016/j.jconrel.2008.11.026
Lipid extrudates as novel sustained release systems for pharmaceutical proteins.
S. Schulze (2009)
10.1080/08982100802636434
Swelling lecithin: cholesterol implants for the controlled release of proteins
R. Tantipolphan (2009)
10.1016/j.jconrel.2009.07.008
Studies on the lipase induced degradation of lipid based drug delivery systems.
M. Schwab (2009)
10.1517/17425247.5.3.291
Lipid implants as drug delivery systems
F. Kreye (2008)
10.1080/10837450.2019.1682607
Pharmaceutical implants: classification, limitations and therapeutic applications
Zahra Mohtashami (2019)
Semantic Scholar Logo Some data provided by SemanticScholar